Invitrogen™ Human BMPR-II ELISA Kit

Ref.: BL-RE-106282Manufacturer ref.: EH50RB 96 tests
€734.00 excl. VAT

Human BMPR-II quantitates human BMPR-II in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human BMPR-II.

Accession number
2610024H22Rik ; AL117858 ; AW546137 ; BB189135 ; récepteur BMP de type II ; récepteur BMP de type-2 ; BMP-2 ; Bmpr2 ; BMPR-2 ; BMPR3 ; BMPRII ; BMPR-II ; BMR2 ; récepteur de la protéine morphogénétique osseuse de type 2 ; récepteur de la protéine morphogénétique osseuse de type II ; récepteur de la protéine morphogénétique osseuse de type 2 ; récepteur de la protéine morphogénétique osseuse de type II (sérine/thréonine kinase) ; récepteur de la protéine morphogénique osseuse de type II (sérine/thréonine kinase) ; BRK-3 ; Gm20272 ; POVD1 ; PPH1 ; T-ALK ; kinase de type récepteur d’activine type II ; récepteur de type II pour la protéine morphogénétique osseuse-4
Dose range
2.5 to 600 pg/ml
Sensitivity of the dosage
2.5 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human BMPR-II quantitates human BMPR-II in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human BMPR-II.

Human BMPR-II quantitates human BMPR-II in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human BMPR-II.

This gene codes a member of the family of bone morphogenetic protein receptors (BMP) of transmembrane serins/threonins kinases. The ligands of these receptors are BMP, which belong to the TGF-beta superfamily. BMPs are involved in the formation and embryogenesis of endochondrial bones. These proteins transfer their signals by forming heteromeric complexes with two different types of serine receptors (threonine) kinase: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. II receptors bind ligands in the absence of Type I receptors, but require their respective Type I receptors for signalling, while Type I receptors require their respective II receptors for ligand binding. Mutations of this gene have been associated with primary pulmonary hypertension, associated with family and fenfluramine, as well as pulmonary venoocclusive disease.

Sensitivity

Sensitivity of the dosage: 2.5 ng/ml.

Measurement range

Dosing range: 2.5 to 600 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: BMPR2.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17134803
Specifications
Accession number2610024H22Rik; AL117858; AW546137; BB189135; Type II BMP receiver; Type-2 BMP receiver; BMP-2; Bmpr2; BMPR-2; BMPR3; BMPRII; BMPR-II; BMR2; type 2 bone morphogenetic protein receptor; type II bone morphogenetic protein receptor; type II bone receptor
Dose range2.5 to 600 pg/ml
Sensitivity of the dosage2.5 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q13873
Gene symbol(s)Bmpr2
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetBMPR2
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH50RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.